| User's Publication |
|
13332
Hase H, Aoki M, Matsumoto K, Nakai S, Nagata T, Takeda A, Ueda K, Minami K, Kitae K, Jingushi K, Ueda Y, Yamamoto M, Furukawa T, Sato M, Tsujikawa K.
Cancer type‑SLCO1B3 promotes epithelial‑mesenchymal transition resulting in the tumour progression of non‑small cell lung cancer.
Oncol Rep
2021
PubMed ID: 33155667
|
|
20104
Abe K, Kanehira M, Ohkouchi S, Kumata S, Suzuki Y, Oishi H, Noda M, Sakurada A, Miyauchi E, Fujiwara T, Harigae H, Okada Y.
Targeting stanniocalcin-1-expressing tumor cells elicits efficient antitumor effects in a mouse model of human lung cancer.
Cancer Med
2021
PubMed ID: 33826244
|
|
12021
Wanna-Udom S, Terashima M, Lyu H, Ishimura A, Takino T, Sakari M, Tsukahara T, Suzuki T.
The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.
Biochem. Biophys. Res. Commun.
2020
PubMed ID: 31982139
|
|
12063
Kuchitsu Y, Nagashio R, Igawa S, Kusuhara S, Tsuchiya B, Ichinoe M, Satoh Y, Naoki K, Murakumo Y, Saegusa M, Sato Y.
TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma.
Biomed. Res.
2020
PubMed ID: 32092740
|
|
11833
Hiyoshi Y, Sato Y, Ichinoe M, Nagashio R, Hagiuda D, Kobayashi M, Kusuhara S, Igawa S, Shiomi K, Goshima N, Murakumo Y, Saegusa M, Satoh Y, Masuda N, Naoki K.
Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.
Thorac Cancer
2019
PubMed ID: 31583841
|
|
11040
Koh Furugaki, Marie Mochizuki, Mirei Kohno, Sei Shu, Naoki Harada, Yasushi Yoshimura
Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion
BMC Cancer
2019
19(1):301
PubMed ID: 30943926
|
|
12502
Hagiuda D, Nagashio R, Ichinoe M, Tsuchiya B, Igawa S, Naoki K, Satoh Y, Murakumo Y, Saegusa M, Sato Y.
Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma
Biomed Res
2019
40(1):17-27
PubMed ID: 30787260
|
|
11223
Terashima M, Ishimura A, Wanna-Udom S, Suzuki T.
MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells.
J. Biol. Chem.
2018
PubMed ID: 30262664
|
|
4183
Ohara K, Ohkuri T, Kumai T, Nagato T, Nozaki Y, Ishibashi K, Kosaka A, Nagata M, Harabuchi S, Ohara M, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H.
Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma.
Oncoimmunology
2018
PubMed ID: 30510853
|
|
9949
Chang H, Sung JH, Moon SU, Kim HS, Kim JW, Lee JS.
EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells.
Yonsei Med. J.
2017
58:9-18
PubMed ID: 27873490
|
|
9950
Terashima M, Tange S, Ishimura A, Suzuki T.
MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.
J. Biol. Chem.
2017
292:82-99
PubMed ID: 27852821
|
|
10280
Seike M, Kim CH, Zou F, Noro R, Chiba M, Ishikawa A, Κunugi S, Kubota K, Gemma A.
AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
Oncol. Rep.
2017
37:3261-3269
PubMed ID: 28440492
|
|
10408
Terashima M, Ishimura A, Wanna-Udom S, Suzuki T.
Epigenetic regulation of epithelial-mesenchymal transition by KDM6A histone demethylase in lung cancer cells.
Biochem. Biophys. Res. Commun.
2017
490:1407-1413
PubMed ID: 28698146
|
|
10464
Reeser JW, Martin D, Miya J, Kautto EA, Lyon E, Zhu E, Wing MR, Smith A, Reeder M, Samorodnitsky E, Parks H, Naik KR, Gozgit J, Nowacki N, Davies KD, Varella-Garcia M, Yu L, Freud AG, Coleman J, Aisner DL, Roychowdhury S.
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.
J Mol Diagn
2017
19:682-696
PubMed ID: 28802831
|
|
10922
Shigeaki Umeda et al
Loss of IL-24 expression facilitates invasion in lung adenocarcinoma
Int J Clin Exp Pathol
2017
10:173-185
|
|
9522
Nishijima N, Seike M, Soeno C, Chiba M, Miyanaga A, Noro R, Sugano T, Matsumoto M, Kubota K, Gemma A.
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells.
Int. J. Oncol.
2016
48:937-44
PubMed ID: 26783187
|
|
12967
Okita R, Yukawa T, Nojima Y, Maeda A, Saisho S, Shimizu K, Nakata M.
MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer
Cancer Immunol Immunother
2016
65(5):499-509.
PubMed ID: 26940474
|
|
7452
Liu G, Wu Q, Liu G, Song X, Zhang J.
Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans.
Cancer Cell Int.
2015
15:18
PubMed ID: 25745359
|
|
13810
Chen S, Huang L, Sun K, Wu D, Li M, Li M, Zhong B, Chen M, Zhang S.
Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis
PLoS One
2015
10(5):e0125480
PubMed ID: 25974088
|
|
4866
Kodama T, Tsukaguchi T, Satoh Y, Yoshida M, Watanabe Y, Kondoh O, Sakamoto H.
Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer.
Mol Cancer Ther
2014
13(12):2910-8
PubMed ID: 25349307
|
|
7714
Huqun, Ishikawa R, Zhang J, Miyazawa H, Goto Y, Shimizu Y, Hagiwara K, Koyama N.
Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer.
Cancer
2012
118:1599-606
PubMed ID: 21837672
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
|
|
2481
Okudela K, Yazawa T, Woo T, Sakaeda M, Ishii J, Mitsui H, Shimoyamada H, Sato H, Tajiri M, Ogawa N, Masuda M, Takahashi T, Sugimura H, Kitamura H.
Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis.
Am J Pathol
2009
175(2):867-81
PubMed ID: 19608870
|
|
12769
Okudela K, Yazawa T, Ishii J, Woo T, Mitsui H, Bunai T, Sakaeda M, Shimoyamada H, Sato H, Tajiri M, Ogawa N, Masuda M, Sugimura H, Kitamura H.
Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis
Am J Pathol
2009
175(6):2646-56
PubMed ID: 19893046
|
|
3580
Ito T, Maki N, Hazeki O, Sasaki K, Nekooki M.
Extracellular and transmembrane region of a podocalyxin-like protein 1 fragment identified from colon cancer cell lines.
Cell Biol Int
2007
31(12):1518-24
PubMed ID: 17719804
|
|
3061
Nagai, Yoshiaki, Miyazawa, Hitoshi, Tanaka, Tomoaki, Udagawa, Kiyoshi, Kato, Motoyasu, Fukuyama, Shunichiro, Yokote, Akemi, Kobayashi, Kunihiko, Kanazawa, Minoru, Hagiwara, Koichi, Hagiwara K
Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.
Cancer Res
2005
65:7276-82
PubMed ID: 16105816
|
|
13698
Matsubara D, Niki T, Ishikawa S, Goto A, Ohara E, Yokomizo T, Heizmann CW, Aburatani H, Moriyama S, Moriyama H, Nishimura Y, Funata N, Fukayama M.
Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes
Cancer Sci
2005
96(12):844-57
PubMed ID: 16367903
|
|
3338
Seike, Masahiro, Kondo, Tadashi, Fujii, Kazuyasu, Yamada, Tesshi, Gemma, Akihiko, Kudoh, Shoji, Hirohashi, Setsuo
Proteomic signature of human cancer cells.
Proteomics
2004
4:2776-88
PubMed ID: 15352251
|
|
13743
Niki T, Kohno T, Iba S, Moriya Y, Takahashi Y, Saito M, Maeshima A, Yamada T, Matsuno Y, Fukayama M, Yokota J, Hirohashi S.
Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas
Am J Pathol
2002
160(3):1129-41
PubMed ID: 11891209
|
|
2483
Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S
Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
Clin Cancer Res
2000
6:2431-9
PubMed ID: 10873096
|
Back
Top
CELL BANK Website